Please forgive the slight inconvenience in creating a new account. Due to juvenile delinquents spamming garbage to the site, we had to install a "Captcha", which can differentiate a spam bot from a human. Once you open your account, confirm it by returning the email, and identifying yourself, we will give you edit privileges. Just request them by leaving a message at click here.

Scenar Therapy

From WikiChiro
Jump to: navigation, search
Template:Infobox association/missing member
RITM Scenar / Tomatex
Logo
Foundation ca. 1980's
Location Taganrog
Country Flag of Russia.png Russian Fed.
President Prof. Dr. Alexander M. Revenko Flag of Russia.png Russian Fed.
Website Scenar Therapy

WikiChiro Resources for

Scenar Therapy

Articles

Most recent articles on Scenar Therapy

Most cited articles on Scenar Therapy

Review articles on Scenar Therapy

Articles on Scenar Therapy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Scenar Therapy

Images of Scenar Therapy

Photos of Scenar Therapy

Podcasts & MP3s on Scenar Therapy

Videos on Scenar Therapy

Evidence Based Medicine

Cochrane Collaboration on Scenar Therapy

Bandolier on Scenar Therapy

TRIP on Scenar Therapy

Clinical Trials

Ongoing Trials on Scenar Therapy at Clinical Trials.gov

Trial results on Scenar Therapy

Clinical Trials on Scenar Therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Scenar Therapy

NICE Guidance on Scenar Therapy

NHS PRODIGY Guidance

FDA on Scenar Therapy

CDC on Scenar Therapy

Books

Books on Scenar Therapy

News

Scenar Therapy in the news

Be alerted to news on Scenar Therapy

News trends on Scenar Therapy

Commentary

Blogs on Scenar Therapy

Definitions

Definitions of Scenar Therapy

Patient Resources / Community

Patient resources on Scenar Therapy

Discussion groups on Scenar Therapy

Patient Handouts on Scenar Therapy

Directions to Hospitals Treating Scenar Therapy

Risk calculators and risk factors for Scenar Therapy

Healthcare Provider Resources

Symptoms of Scenar Therapy

Causes & Risk Factors for Scenar Therapy

Diagnostic studies for Scenar Therapy

Treatment of Scenar Therapy

Continuing Medical Education (CME)

CME Programs on Scenar Therapy

International

Scenar Therapy en Espanol

Scenar Therapy en Francais

Business

Scenar Therapy in the Marketplace

Patents on Scenar Therapy

Experimental / Informatics

List of terms related to Scenar Therapy

The Scenar device, is the latest incarnation of an electronic instrument developed by scientists working in the Russian aerospace industry, in the town of Taganrog, Russia. The name is an acronym derived from "Self Controlled Energo-Neuro-adaptive Regulation". It has, in earlier incarnations been known as the "Inter-X -5002". Prof. Dr. Alexander M. Revenko (neurology) is the founder of Scenar medicine. [1]

Description

RITM Scenar Sport D.jpeg

The device is sold for the treatment of acute and chronic pain, and is represented as being useful in solo therapy as well as in combination with other therapeutic modalities, as it "has very few contraindications" [1].

Scenar is represented as being capable of interaction with the nervous, immune and endocrine systems through a biofeedback mechanism. It is believed that it "ensures regulation of various mediators and neuropeptides". And, it main goal is the maintenance of homeostasis through interactions with the body's immune and hormonal systems[1].

History

In the beginning, there the SCENAR-035, or 'troika', as it is pronounced in Russian. The Grandmother of SCENARs. It was a good, reliable, stable, and effective model. Not very pretty on the outside, in a black rectangular case, yet nevertheless very functional. SCENAR-035 is known mostly just inside Russia, and some doctors work with it even now. In fact, those almost unbelievable SCENAR results reported by Dr. Yuri Gorfinkel and Dr Revenko in 1998 in his famous Summary of individual results (which appears all over the SCENAR literature) were obtained mostly with the SCENAR-035. This model was designed by Dr. Karasev and massively produced by OKB Ritm.

FDA Approvals

Scenar technology is, as of May, 2010, an FDA approved device, for treatment of pain, under the following class: DEVICE: SCENAR, MODEL 10, RITM OKB ZAO 510(k) NO: K092117(TRADITIONAL). It is cleared for the treatment and management of acute and chronic pain and the management of post-surgical and post-traumatic pain. It may be dispensed only upon the prescription of a licensed health care provider.[2]

Waveforms

Scenar waveforms 1a.jpg Scenar waveforms 1b.jpg Scenar waveforms 2.jpg

Scientific Research

Several studies have shown benefits in treatment of various conditions, most of which demonstrate results significantly greater than could be explained by placebo alone. Some studies the company provides were never published, but were performed at their request, however there are some rather interesting and positive results.

Enuresis

  • 1995 - V.A Lebedev (Physiotherapist), reported in the journal Вопросы курортологии, физиотерапии и лечебной физкультуры (Investigations in therapeutic spas, physiotherapy and therapeutic physical culture), that he "recommends a self-control energoneuroadaptive regulator (SCENAR) as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis. This regulator operates according to the principles of Chinese medicine and may be used in sanatoria and at home by the children's parents specially trained by physiotherapist" [3].

Pain

  • 2004 - Lopatina, A.B, reported in a Dissertation for her Doctorate in Education, that the Scenar had shown benefits in "speeding the recovery period in athletes" [4].
  • 2005 - A study of 60 patients post trochanteric joint surgery, with the early model Scenar (InterX) device, run in Moscow, Russia and published in the Journal of Bone and Joint Surgery, Gorodetskiy et al, conclude that the scenar treated patients had significantly reduced pain as compared to the sham (placebo) or for the "non-invasive neuro-stimulation" groups. [5].
  • 2006 - Presenting at the XVth International Congress on Sports rehabilitation and Traumatology, P. Massetti gave a case study of two young men, 6 months post contusion; one 24 years old, with tears of the femoris and medial vastus lateralis, after 7 treatments showed significant reduction in pain, and increased range-of-motion, and after one week of treatment, the symptoms "were completely resolved" ; and the other 38 years old, with strain of the tibialis medius, interfering with his ability to participate in sports. His pain extended into the insertion of the Achilles tendon. His treatment was 2x week, together with CO2 laser and ultrasound. Following 10 applications of alternating laser+ultrasound and Scenar therapy the patient had a complete remission of symptoms [6].
  • 2006 - At the same Congress in which he gave his case report, Massetti published a paper in which he indicates having treated 20 patients, including both professional and amateur athletes with varying painful conditions. According to his report, all of the patients, after 2 treatments, 2x/week demonstrated "significant reduction in symptoms" unexplainable as resulting from any other possible cause. Massetti concludes that the Scenar "is an instrument capable of drastically reducing the time of recuperation in significant traumatic events" , [7]
  • 2007 - At the WACBE World Congress of Bioengineering, Han In Bo, et al, reported on 202 patients with Myofascial Pain Syndrome (MPS), who were treated over periods ranging from 3-16 months, for 5 min. each time. The results reported were an 89% overall reduction in pain, which was still reported after a 6 month follow up. [8]
  • 2008 - Writing about his experiences at the European Speed Skating championships (Germany) and the subsequent World's in Spain, Rosario Bella, (a Physiotherapist) for the FIHP (Roller Hockey), in a report published at the medical site FCE news, of Scenar use together with kinesiotaping, states, that the "results were appreciable in noting the time of recuperation and eduction of symptoms to a tolerable level in a good percentage of the cases treated, even during the competition". And, that the SCENAR taken together with the taping provided a synergistic effect, then when taken alone. [9]
  • 2010 - With results similar to their 2005 study, Gorodetskiy, et al, publishing in The Journal of Foot and Ankle Surgery in 2010, found results comparable to their earlier study, in patients post malleolar (ankle joint) fracture surgery [10].

Post-herpetic neuralgia

  • 2007 - M.R. Ing, publishing in the Hawaii Medical Journal, treated three consecutive patients with post-herpetic neuralgia and found that ALL resolved their pain in no more than 5 sessions over a three week period [11].

Duodenal ulcer

  • 2006 - In a study published in Клиническая Медицина (Clinical medicine), Tsimmerman, et al, reported that 103 cases of duodenal ulcer were treated with Scenar alone and together with standard therapy for H pylori. They determined that "led to positive changes in most of the parameters under study", and "Addition of SCENAR therapy to the complex conventional pharmacotherapy [sic] 'sped up' ulcer healing, increased the effectiveness of Helicobacter pylori eradication, and improved the condition of the gastroduodenal mucosa" [12].

See also

References

  1. 1.0 1.1 1.2 Scenar medical technology, Taganrog Russian Fed.: Scenar, Aug. 3, 2011, pp. 6 
  2. "May 2010 510(k) Clearances". FDA website. FDA. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/ucm214678.htm?utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=Scenar&utm_content=6. 
  3. Lebedev, V.A. (July-Aug, 1995). "The treatment of neurogenic bladder dysfunction with enuresis in children using the SKENAR apparatus" (in Russian). Вопросы курортологии, физиотерапии и лечебной физкультуры (Russia) 4: 25-26. http://www.ncbi.nlm.nih.gov/pubmed/8779182. Retrieved 4/8/2012. 
  4. Lopatina, Anna B. (2004), "Comparison of he effectiveness of SMC and SCENAR influence in Recovery of the Body Functions of Sportsmen after training" (in Russian), disserCat — электронная библиотека диссертаций: 155pgs, http://www.dissercat.com/content/otsenka-effektivnosti-skenar-vozdeistviya-v-trenirovochnom-protsesse-vysokokvalifitsirovanny?_openstat=cmVmZXJ1bi5jb207bm9kZTthZDE7 
  5. Gorodetskiy, I.G.; Gorodnichenko, A.I., et al (Sept 2007). "Non Invasive interactive neurostimulation in the post-operative recovery of patients with a trochanteric fracture of the femur" (in English). The Journal of Bone and Joint Surgery (Journal of Bone and Joint Surgery) 89-B (11): 1488-1494. 
  6. Massetti, P. (2006). "Scenar: nuovo approccio diagnostico-terapeutico. Nostre esperienze in traumatologigia sportivo" (in Italian). Proc. of the XVth International Congress on Sports Rehabilitation and Traumatology (IsoKinetic) The Rehabilitation of Winter and Mountain Sports Injuries. 
  7. Massetti, P. (2006). "Nuroregolatore interattivo scenar: Nostre esperienze in traumatologigia sportivo e post chirugica" (in Italian). Proc. of the XVth International Congress on Sports Rehabilitation and Traumatology The Rehabilitation of Winter and Mountain Sports Injuries (7): 86-87. 
  8. Han, MD, et al, In Bo (2007). "Scenar therapy for Myofascial Pain Syndrome" (in English). Proc. of WACBE World Congress on Bioengineering. WACBE Congress. http://www.scenar.com.au/docsys/download.php?&docid=80. Retrieved 4/24/2012. 
  9. Bella, Rosario (2008). "Traumatologia nel pattinaggio a rotelle corsa: utilizzo dell’InterX e del taping kinesiologico nei piccoli traumi da sport" (in Italian). Report to FIHP medical commission, from European and World Championships. fceonline.it. http://www.fceonline.it/wikimedicina/altri-argomenti/1888-traumatologia-nel-pattinaggio-rotelle-corsa-utilizzo.html. Retrieved 4/8/2012. 
  10. Gorodetskiy, I.G.; Gorodnichenko, A.I., et al (2010). "Use of non-invasive NeuroStimulation to improve Short-term recovery in Patients with Surgically repaired Ankle Fractures: A Prospective, Randomized Trial" (in English). The Journal of Foot and Ankle Surgery (Journal of Foot and Ankle Surgery) 49: 432-437. 
  11. Ing, M.R. (Sept,2007). "The use of electronic biofeedback for the management of post-herpetic neuralgia--a report of 3 cases" (in English). Hawaii Medical Journal (Honolulu, HI: Hawaii Medical Journal) 66 (9): 232-234. http://www.ncbi.nlm.nih.gov/pubmed/20879466. Retrieved 4/2012. 
  12. Tsimmerman, IaS; Kochurova IA, Vladimirskiĭ EV. (2006). "The effectiveness of SCENAR therapy in complex treatment of duodenal ulcer, and the mechanisms of its action" (in Russian). Клиническая Медицина (Moscow, RF) 84 (7): 35-41. http://www.ncbi.nlm.nih.gov/pubmed/16924799. Retrieved 4/8/2012. 

Corporate information

RITM SCENAR ® Medical Device

RITM OKB ZAO
Russian Fed. Scenar Website
Foundation: ca. 1980's
Location: Taganrog
Country: Russian Fed.

SCENAR ACADEMY
President: Prof. Dr. Alexander N. Revenko
Russian Fed. Scenar Therapy Website
Location: Moscow
Country: Russian Fed.

TOMATEX LLC
Scenar licensed Distributor and Training Provider
Location:Dallas, TEXAS Tomatex WebSite
Country: USA

External links

Tomatex - Scenar Therapy